Sally I. Eissa

703 total citations
16 papers, 602 citations indexed

About

Sally I. Eissa is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Sally I. Eissa has authored 16 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Sally I. Eissa's work include Synthesis and biological activity (11 papers), Quinazolinone synthesis and applications (4 papers) and Synthesis and Biological Evaluation (4 papers). Sally I. Eissa is often cited by papers focused on Synthesis and biological activity (11 papers), Quinazolinone synthesis and applications (4 papers) and Synthesis and Biological Evaluation (4 papers). Sally I. Eissa collaborates with scholars based in Egypt, Saudi Arabia and Slovakia. Sally I. Eissa's co-authors include Yousry A. Ammar, Mohamed Ayman El‐Zahabi, Hazem Elkady, Amel M. Farrag, Ahmed B. M. Mehany, Eman A. Fayed, Ibrahim H. Eissa, Abdallah E. Abdallah, Khaled El‐Adl and Helmy Sakr and has published in prestigious journals such as Bioorganic & Medicinal Chemistry, New Journal of Chemistry and Journal of Molecular Structure.

In The Last Decade

Sally I. Eissa

16 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally I. Eissa Egypt 11 458 250 77 75 50 16 602
Ahmed B. M. Mehany Egypt 12 418 0.9× 206 0.8× 66 0.9× 54 0.7× 56 1.1× 24 531
G. Bharath Kumar India 19 695 1.5× 286 1.1× 75 1.0× 63 0.8× 63 1.3× 30 888
Kamal M. El‐Gamal Egypt 11 510 1.1× 270 1.1× 72 0.9× 81 1.1× 74 1.5× 14 655
Mohamed Ayman El‐Zahabi Egypt 15 519 1.1× 420 1.7× 127 1.6× 115 1.5× 45 0.9× 43 751
Rajesh Kakadiya Taiwan 16 506 1.1× 335 1.3× 86 1.1× 37 0.5× 26 0.5× 35 695
Haytham O. Tawfik Egypt 19 434 0.9× 329 1.3× 102 1.3× 49 0.7× 59 1.2× 56 694
Heba S. A. Elzahabi Egypt 17 761 1.7× 252 1.0× 80 1.0× 58 0.8× 97 1.9× 35 912
Dong Cao China 11 424 0.9× 285 1.1× 96 1.2× 67 0.9× 30 0.6× 20 622
Souad A. El‐Metwally Egypt 11 465 1.0× 252 1.0× 89 1.2× 86 1.1× 60 1.2× 22 592
Heba A. Hassan Egypt 14 387 0.8× 261 1.0× 94 1.2× 22 0.3× 50 1.0× 31 595

Countries citing papers authored by Sally I. Eissa

Since Specialization
Citations

This map shows the geographic impact of Sally I. Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally I. Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally I. Eissa more than expected).

Fields of papers citing papers by Sally I. Eissa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally I. Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally I. Eissa. The network helps show where Sally I. Eissa may publish in the future.

Co-authorship network of co-authors of Sally I. Eissa

This figure shows the co-authorship network connecting the top 25 collaborators of Sally I. Eissa. A scholar is included among the top collaborators of Sally I. Eissa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally I. Eissa. Sally I. Eissa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Helal, Mohamed H., Ahmed Ragab, Moustafa S. Abusaif, et al.. (2025). Rational design, synthesis, and in silico evaluation of novel pyridine-based heterocyclic compounds as multifunctional antidiabetic agents: molecular docking and ADMET profiling. Journal of Molecular Structure. 1349. 143703–143703. 3 indexed citations
2.
Elkady, Hazem, et al.. (2023). Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis. Archiv der Pharmazie. 356(9). e2300097–e2300097. 28 indexed citations
3.
El‐Zahabi, Mohamed Ayman, et al.. (2023). Design, synthesis, anticancer evaluation, in silico docking and ADMET analysis of novel indole-based thalidomide analogs as promising immunomodulatory agents. Journal of Biomolecular Structure and Dynamics. 41(24). 15106–15123. 19 indexed citations
4.
Abdallah, Abdallah E., Sally I. Eissa, Eslam B. Elkaeed, et al.. (2022). Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 573–591. 46 indexed citations
5.
Abdallah, Abdallah E., et al.. (2021). Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. Bioorganic Chemistry. 109. 104695–104695. 54 indexed citations
6.
Eissa, Sally I., Amel M. Farrag, Samir Y. Abbas, et al.. (2021). Novel structural hybrids of quinoline and thiazole moieties: Synthesis and evaluation of antibacterial and antifungal activities with molecular modeling studies. Bioorganic Chemistry. 110. 104803–104803. 91 indexed citations
7.
Eissa, Ibrahim H., Mohammed A. Dahab, Mohamed K. Ibrahim, et al.. (2021). Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorganic Chemistry. 112. 104965–104965. 57 indexed citations
8.
Abdallah, Abdallah E., Mohamed S. Alesawy, Sally I. Eissa, et al.. (2021). Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and in vitro antiviral screening. New Journal of Chemistry. 45(36). 16557–16571. 54 indexed citations
9.
El‐Zahabi, Mohamed Ayman, Helmy Sakr, Khaled El‐Adl, et al.. (2020). Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry. 104. 104218–104218. 91 indexed citations
10.
Harras, Marwa F., Rehab Sabour, Yousry A. Ammar, et al.. (2020). Design synthesis and cytotoxicity studies of some novel indomethacin-based heterocycles as anticancer and apoptosis inducing agents. Journal of Molecular Structure. 1228. 129455–129455. 10 indexed citations
12.
Shehry, Mohamed F. El, et al.. (2018). Design, synthesis and biological evaluation of quinoxaline N-propionic and O-propionic hydrazide derivatives as antibacterial and antifungal agents. Medicinal Chemistry Research. 27(10). 2287–2296. 22 indexed citations
13.
Eissa, Sally I., Amel M. Farrag, Taghreed Z. Shawer, & Yousry A. Ammar. (2017). Design, synthesis, 3D pharmacophore, QSAR, and docking studies of some new (6-methoxy-2-naphthyl) propanamide derivatives with expected anti-bacterial activity as FABI inhibitor. Medicinal Chemistry Research. 26(10). 2375–2398. 2 indexed citations
14.
Eissa, Sally I.. (2017). Synthesis, characterization and biological evaluation of some new indomethacin analogs with a colon tumor cell growth inhibitory activity. Medicinal Chemistry Research. 26(9). 2205–2220. 3 indexed citations
15.
Abbas, Hebat‐Allah S., et al.. (2015). Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase. Bioorganic & Medicinal Chemistry. 23(20). 6560–6572. 75 indexed citations
16.
Eissa, Sally I., et al.. (2014). Non-carboxylic Analogues of Aryl Propionic Acid: Synthesis, Anti-inflammatory, Analgesic, Antipyretic and Ulcerogenic Potential. Drug Research. 64(9). 485–492. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026